Both in Pharmaceuticals
CDT Equity vs Lakewood-Amedex Biotherapeutics
Over the past year CDT returned −99.3% and LABT returned −75.6%; their daily moves had a correlation of -0.13.
CDT −99.3% LABT −75.6%Growth of $1, one year, split-adjusted
| Metric | CDT | LABT |
|---|---|---|
| Price | $0.0423 | $0.5406 |
| Market cap | $32.6K | $1.3M |
| Today | −16.90% | +182.45% |
| 1 month | −94.9% | −36.4% |
| 6 months | −100.0% | — |
| Year to date | −100.0% | — |
| 1 year | −100.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $4.6M |
| Dividend yield | — | — |
| Volatility (60d) | 991.2% | — |
| Short % of float | 18.8% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).